CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Amazon Explores AI Content Marketplace With Media Publishers 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
DENVER, Dec. 18, 2017 -- BurstIQ, Inc. a leading enterprise-level blockchain healthcare data company, today announced that it has filed provisional patent applications covering uses of blockchain to enable mobile crypto-currency wallets. The patent applications incorporate the IP of both BurstIQ’s proprietary blockchain machine intelligence platform and proprietary eWallet technology and payment platform by partner Unified Signal. Once granted, these new patents will expand BurstIQ’s intellectual property portfolio and provide foundational support for the company’s commercial roadmap. BurstIQ will own worldwide rights for each patent.
"Given that the BurstIQ platform is truly the first of its kind, having a strong patent estate is essential - both to protect our blockchain healthcare data platform and future marketplace and to strengthen our competitive position in the market,” said Frank Ricotta, CEO of BurstIQ. “We intend to leverage our proprietary blockchain platform with healthcare, digital health, insurance and mobile partners. When granted, these newly filed patent applications will significantly strengthen our intellectual property portfolio and support development and commercialization of our cutting-edge blockchain platform and health marketplace. The BurstIQ platform is designed to increase access to health services, improve health outcomes and reduce costs across the healthcare industry. These patents are an important step in that process.”
About BurstIQ ™
BurstIQ ™ is a leading enterprise-level healthcare blockchain data company. The company offers a HIPAA-compliant platform that seamlessly leverages blockchain, advanced security, Big Data capabilities and machine intelligence to enable healthcare businesses and individuals to access, understand, and control their health data. The BurstIQ Ecosystem allows people and businesses to transact through a network of marketplaces for personalized products and services, value-added B2B services, research opportunities, and peer-to-peer networks. The BurstIQ platform and Ecosystem work together to improve the security of health data, increase health access and personal empowerment, reduce healthcare costs, and enable new insights and care models. It’s not just your data. It’s your life.
For more information visit www.BurstIQ.com
Contacts:
PR & Media Contact:
Matthew BIRD, CEO
1-800-PublicRelations (1800pr)
O: 646.248.7676
E: [email protected]
BurstIQ:
Amber Hartley, Chief Corporate Development Officer
E: [email protected]
W: www.burstIQ.com
